Conscience April 2025 Policy Brief - FDA Announces Plan to Phase Out Animal Testing Requirement for Drug Development

FDA Announces Plan to Phase Out Animal Testing Requirement for Drug Development On April 10, the US Food and Drug Administration (FDA) announced that it would begin the process of phasing out animal testing in the development of monoclonal antibody therapies and other drugs to reduce research and development costs and, by extension, drug prices This policy brief describes how the new regulations relate to current and pending legislation, the alternative sources data can be derived from, and how this new regime could lead to cost savings in drug development.